J. Thomas Schuetz's most recent trade in Compass Therapeutics Inc was a trade of 10,000 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on May 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.11 per share. | 27 May 2025 | 10,000 | 6,480,825 | - | 2.1 | 21,100 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 1,500,000 | 1,500,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.50 per share. | 08 Feb 2025 | 41,687 | 6,470,825 | - | 3.5 | 145,905 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.86 per share. | 09 Jan 2025 | 58,054 | 6,512,512 | - | 1.9 | 107,980 | Common Stock |
| Compass Therapeutics Inc | J. Thomas Schuetz | Director, PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. | 08 Feb 2024 | 44,782 | 6,570,566 | - | 1.5 | 64,934 | Common Stock |
| Compass Therapeutics Inc | Schuetz Thomas J. | Director, President of R&D | Grant, award, or other acquisition of securities at price $ 1.93 per share. | 09 Jan 2024 | 637,500 | 6,615,348 | - | 1.9 | 1,230,375 | Common Stock |
| Compass Therapeutics Inc | J. Schuetz Thomas | Director, President of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 637,500 | 637,500 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 3.37 per share. | 10 Mar 2023 | 10,000 | 6,021,873 | - | 3.4 | 33,700 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 27 Feb 2023 | 20,000 | 6,011,873 | - | 4.0 | 79,600 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 3.86 per share. | 15 Feb 2023 | 20,000 | 5,991,873 | - | 3.9 | 77,200 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 500,000 | 5,971,873 | - | 0 | Common Stock | |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 4.05 per share. | 31 Jan 2023 | 20,000 | 5,471,873 | - | 4.1 | 81,000 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 4.19 per share. | 24 Jan 2023 | 20,000 | 5,451,873 | - | 4.2 | 83,800 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.32 per share. | 28 Sep 2022 | 10,000 | 5,431,873 | - | 2.3 | 23,200 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.27 per share. | 26 Sep 2022 | 15,000 | 5,421,873 | - | 2.3 | 34,050 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 3.03 per share. | 07 Sep 2022 | 15,000 | 5,406,873 | - | 3.0 | 45,450 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.83 per share. | 01 Sep 2022 | 15,000 | 5,391,873 | - | 2.8 | 42,450 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 3.05 per share. | 17 Aug 2022 | 15,000 | 5,376,873 | - | 3.1 | 45,750 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.64 per share. | 10 Aug 2022 | 15,000 | 5,361,873 | - | 2.6 | 39,600 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.58 per share. | 01 Aug 2022 | 15,000 | 5,346,873 | - | 2.6 | 38,700 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.80 per share. | 21 Jun 2022 | 20,000 | 5,331,873 | - | 2.8 | 56,000 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.34 per share. | 16 Jun 2022 | 20,000 | 5,311,873 | - | 2.3 | 46,800 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.29 per share. | 13 Jun 2022 | 30,000 | 5,291,873 | - | 2.3 | 68,700 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.83 per share. | 06 Jun 2022 | 30,000 | 5,261,873 | - | 2.8 | 84,900 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 3.03 per share. | 01 Jun 2022 | 20,000 | 5,231,873 | - | 3.0 | 60,600 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 3.04 per share. | 26 May 2022 | 20,000 | 5,211,873 | - | 3.0 | 60,800 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.72 per share. | 23 May 2022 | 18,355 | 5,191,873 | - | 2.7 | 49,926 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.47 per share. | 17 May 2022 | 20,215 | 5,173,518 | - | 2.5 | 49,931 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.80 per share. | 10 May 2022 | 27,836 | 5,153,303 | - | 1.8 | 50,105 | Common Stock |
| Compass Therapeutics Inc | Thomas J. Schuetz | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 600,000 | 5,125,467 | - | 0 | Common Stock |